T lymphocytes play a pivotal role in resolving hepatitis B virus infection. This study aimed to investigate the dynamics of peripheral blood T ...

Researchers have uncovered how chronic hepatitis C infection leads to autoimmune disease, which opens new paths for treatments ...

Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, ...

Garvan Institute researchers discovered how chronic hepatitis C virus (HCV) infections lead to autoimmune diseases like ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

Investors clearly appreciate the song Tune Therapeutics is singing, handing over $175 million in series B funds as the ...

The following is a summary of “Cobalt chloride-mimicked hepatocyte cell hypoxia induces TREX1 leading to Hepatitis B virus ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest ...

A Durham biotech firm founded on technology built at Duke University has raised $175 million to fund clinical trials of its ...

With engineered T-cell therapies becoming more widely used to treat malignancies, including Hepatitis B virus-induced liver cancer and a range of blood cancers, being able to accurately and easily ...